Jazz Pharmaceuticals plc Increase (Decrease) in Accounts Receivable
Jazz Pharmaceuticals plc (JAZZ) reported Increase (Decrease) in Accounts Receivable of $51.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-03
- Jazz Pharmaceuticals plc increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $44.90M, a 19.10% decline year-over-year.
- Jazz Pharmaceuticals plc increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $6.50M.
- Jazz Pharmaceuticals plc increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $65.81M.
- Jazz Pharmaceuticals plc increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $50.97M, a 129.00% increase year-over-year.
- Jazz Pharmaceuticals plc increase (decrease) in accounts receivable for fiscal 2025 was $106.28M, a 403.33% increase from fiscal 2024.
- Jazz Pharmaceuticals plc increase (decrease) in accounts receivable for fiscal 2024 was $21.11M, a 59.30% decline from fiscal 2023.
- Jazz Pharmaceuticals plc increase (decrease) in accounts receivable for fiscal 2023 was $51.88M, a 42.44% decline from fiscal 2022.
- Jazz Pharmaceuticals plc increase (decrease) in accounts receivable for fiscal 2022 was $90.14M, a 2.80% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $51.40M 10-Q · filed 2026-08-03 | $117.21M derived: sum of 3 quarters · filed 2026-08-03 | $168.18M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | $6.50M 10-Q · filed 2026-05-05 | $72.31M derived: sum of 2 quarters · filed 2026-05-05 | $123.28M derived: sum of 3 quarters · filed 2026-05-05 | $178.78M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | $65.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $116.78M derived: sum of 2 quarters · filed 2026-02-24 | $172.28M derived: sum of 3 quarters · filed 2026-08-03 | $106.28M 10-K · filed 2026-02-24 | ||
| 2025-09-30 | $50.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $106.47M derived: sum of 2 quarters · filed 2026-08-03 | $40.47M 10-Q · filed 2025-11-05 | $39.60M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | $55.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$10.50M 10-Q · filed 2026-08-03 | -$10.53M 10-Q · filed 2025-08-06 | -$11.36M derived: sum of 3 quarters · filed 2026-08-03 | $10.89M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-03-31 | -$66.00M 10-Q · filed 2026-05-05 | -$66.05M 10-Q · filed 2025-05-07 | -$66.86M derived: sum of 2 quarters · filed 2026-05-05 | -$44.61M derived: sum of 3 quarters · filed 2026-05-05 | -$53.33M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | -$864.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $21.39M derived: sum of 2 quarters · filed 2026-02-24 | $12.67M derived: sum of 3 quarters · filed 2026-02-24 | $21.11M 10-K · filed 2026-02-24 | ||
| 2024-09-30 | $22.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $13.54M derived: sum of 2 quarters · filed 2025-11-05 | $21.98M 10-Q · filed 2025-11-05 | $97.44M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-06-30 | -$8.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$277.00K 10-Q · filed 2025-08-06 | $75.19M derived: sum of 3 quarters · filed 2026-02-24 | $94.05M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | $8.44M 10-Q · filed 2025-05-07 | $83.91M derived: sum of 2 quarters · filed 2026-02-24 | $102.77M derived: sum of 3 quarters · filed 2026-02-24 | $88.79M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2023-12-31 | $75.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $94.32M derived: sum of 2 quarters · filed 2026-02-24 | $80.34M derived: sum of 3 quarters · filed 2026-02-24 | $51.88M 10-K · filed 2026-02-24 | ||
| 2023-09-30 | $18.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $4.88M derived: sum of 2 quarters · filed 2024-11-07 | -$23.58M 10-Q · filed 2024-11-07 | $22.69M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-06-30 | -$13.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$42.44M 10-Q · filed 2024-08-01 | $3.83M derived: sum of 3 quarters · filed 2025-02-26 | $13.46M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-03-31 | -$28.46M 10-Q · filed 2024-05-02 | $17.81M derived: sum of 2 quarters · filed 2025-02-26 | $27.44M derived: sum of 3 quarters · filed 2025-02-26 | $51.95M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2022-12-31 | $46.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $55.90M derived: sum of 2 quarters · filed 2025-02-26 | $80.41M derived: sum of 3 quarters · filed 2025-02-26 | $90.14M 10-K · filed 2025-02-26 | ||
| 2022-09-30 | $9.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $34.15M derived: sum of 2 quarters · filed 2023-11-08 | $43.87M 10-Q · filed 2023-11-08 | $108.65M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $24.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $34.23M 10-Q · filed 2023-08-09 | $99.01M derived: sum of 3 quarters · filed 2024-02-28 | $92.13M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $9.72M 10-Q · filed 2023-05-10 | $74.50M derived: sum of 2 quarters · filed 2024-02-28 | $67.62M derived: sum of 3 quarters · filed 2024-02-28 | $84.21M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $64.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $57.90M derived: sum of 2 quarters · filed 2024-02-28 | $74.49M derived: sum of 3 quarters · filed 2024-02-28 | $92.73M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | -$6.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $9.71M derived: sum of 2 quarters · filed 2022-11-09 | $27.96M 10-Q · filed 2022-11-09 | $61.60M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | $16.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $34.84M 10-Q · filed 2022-08-03 | $68.48M derived: sum of 3 quarters · filed 2023-03-01 | $77.13M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $18.25M 10-Q · filed 2022-05-04 | $51.89M derived: sum of 2 quarters · filed 2023-03-01 | $60.53M derived: sum of 3 quarters · filed 2023-03-01 | $94.75M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $33.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $42.29M derived: sum of 2 quarters · filed 2023-03-01 | $76.51M derived: sum of 3 quarters · filed 2023-03-01 | $38.65M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | $8.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $42.87M derived: sum of 2 quarters · filed 2021-11-09 | $5.00M 10-Q · filed 2021-11-09 | $93.02M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $34.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$3.64M 10-Q · filed 2021-08-03 | $84.38M derived: sum of 3 quarters · filed 2022-03-01 | $41.11M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | -$37.86M 10-Q · filed 2021-05-04 | $50.16M derived: sum of 2 quarters · filed 2022-03-01 | $6.89M derived: sum of 3 quarters · filed 2022-03-01 | -$2.50M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $88.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $44.75M derived: sum of 2 quarters · filed 2022-03-01 | $35.37M derived: sum of 3 quarters · filed 2022-03-01 | $92.33M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | -$43.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | -$52.65M derived: sum of 2 quarters · filed 2020-11-02 | $4.31M 10-Q · filed 2020-11-02 | -$11.08M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-06-30 | -$9.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $47.57M 10-Q · filed 2020-08-04 | $32.19M derived: sum of 3 quarters · filed 2021-02-23 | $33.35M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-03-31 | $56.96M 10-Q · filed 2020-05-05 | $41.57M derived: sum of 2 quarters · filed 2021-02-23 | $42.74M derived: sum of 3 quarters · filed 2021-02-23 | $40.50M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2018-12-31 | -$15.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | -$14.22M derived: sum of 2 quarters · filed 2021-02-23 | -$16.46M derived: sum of 3 quarters · filed 2021-02-23 | $40.13M 10-K · filed 2021-02-23 | ||
| 2018-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$1.07M derived: sum of 2 quarters · filed 2019-11-05 | $55.52M 10-Q · filed 2019-11-05 | $20.97M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-06-30 | -$2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $54.36M 10-Q · filed 2019-08-06 | $19.80M derived: sum of 3 quarters · filed 2020-02-25 | $39.04M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-03-31 | $56.59M 10-Q · filed 2019-05-07 | $22.04M derived: sum of 2 quarters · filed 2020-02-25 | $41.27M derived: sum of 3 quarters · filed 2020-02-25 | $35.83M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2017-12-31 | -$34.55M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$15.32M derived: sum of 2 quarters · filed 2020-02-25 | -$20.76M derived: sum of 3 quarters · filed 2020-02-25 | -$12.28M 10-K · filed 2020-02-25 | ||
| 2017-09-30 | $19.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $13.79M derived: sum of 2 quarters · filed 2018-11-06 | $22.27M 10-Q · filed 2018-11-06 | $19.60M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-06-30 | -$5.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $3.04M 10-Q · filed 2018-08-07 | $367.00K derived: sum of 3 quarters · filed 2019-02-26 | $6.48M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-03-31 | $8.48M 10-Q · filed 2018-05-08 | $5.81M derived: sum of 2 quarters · filed 2019-02-26 | $11.93M derived: sum of 3 quarters · filed 2019-02-26 | $20.28M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2016-12-31 | -$2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $3.44M derived: sum of 2 quarters · filed 2019-02-26 | $11.80M derived: sum of 3 quarters · filed 2019-02-26 | $25.60M 10-K · filed 2019-02-26 | ||
| 2016-09-30 | $6.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $14.47M derived: sum of 2 quarters · filed 2017-11-07 | $28.27M 10-Q · filed 2017-11-07 | $42.45M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-06-30 | $8.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $22.16M 10-Q · filed 2017-08-08 | $36.34M derived: sum of 3 quarters · filed 2018-02-27 | $38.52M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-03-31 | $13.80M 10-Q · filed 2017-05-09 | $27.98M derived: sum of 2 quarters · filed 2018-02-27 | $30.16M derived: sum of 3 quarters · filed 2018-02-27 | $33.87M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $14.18M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $16.36M derived: sum of 2 quarters · filed 2018-02-27 | $20.07M derived: sum of 3 quarters · filed 2018-02-27 | $24.84M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $2.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $5.89M derived: sum of 2 quarters · filed 2016-11-08 | $10.66M 10-Q · filed 2016-11-08 | $15.01M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | $3.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $8.48M 10-Q · filed 2016-08-09 | $12.83M derived: sum of 3 quarters · filed 2017-02-28 | $41.63M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-03-31 | $4.77M 10-Q · filed 2016-05-10 | $9.12M derived: sum of 2 quarters · filed 2017-02-28 | $37.92M derived: sum of 3 quarters · filed 2017-02-28 | $43.80M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2014-12-31 | $4.35M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $33.15M derived: sum of 2 quarters · filed 2017-02-28 | $39.03M derived: sum of 3 quarters · filed 2017-02-28 | $55.04M 10-K · filed 2017-02-28 | ||
| 2014-09-30 | $28.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $34.68M derived: sum of 2 quarters · filed 2015-11-09 | $50.69M 10-Q · filed 2015-11-09 | $61.89M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-06-30 | $5.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $21.89M 10-Q · filed 2015-08-05 | $33.09M derived: sum of 3 quarters · filed 2016-02-23 | $31.72M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-03-31 | $16.01M 10-Q · filed 2015-05-07 | $27.21M derived: sum of 2 quarters · filed 2016-02-23 | $25.84M derived: sum of 3 quarters · filed 2016-02-23 | $45.95M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2013-12-31 | $11.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $9.83M derived: sum of 2 quarters · filed 2016-02-23 | $29.93M derived: sum of 3 quarters · filed 2016-02-23 | $48.85M 10-K · filed 2016-02-23 | ||
| 2013-09-30 | -$1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $18.74M derived: sum of 2 quarters · filed 2014-11-04 | $37.65M 10-Q · filed 2014-11-04 | $24.60M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | $20.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $39.02M 10-Q · filed 2014-08-05 | $25.97M derived: sum of 3 quarters · filed 2015-02-24 | $36.31M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-03-31 | $18.91M 10-Q · filed 2014-05-08 | $5.86M derived: sum of 2 quarters · filed 2015-02-24 | $16.21M derived: sum of 3 quarters · filed 2015-02-24 | $14.84M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2012-12-31 | -$13.05M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$2.70M derived: sum of 2 quarters · filed 2015-02-24 | -$4.07M derived: sum of 3 quarters · filed 2015-02-24 | $4.72M 10-K · filed 2015-02-24 | ||
| 2012-09-30 | $10.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $8.98M derived: sum of 2 quarters · filed 2013-11-05 | $17.77M 10-Q · filed 2013-11-05 | $20.72M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-06-30 | -$1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $7.43M 10-Q · filed 2013-08-06 | $10.37M derived: sum of 3 quarters · filed 2014-02-25 | $16.80M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-03-31 | $8.79M 10-Q · filed 2013-05-07 | $11.74M derived: sum of 2 quarters · filed 2014-02-25 | $18.17M derived: sum of 3 quarters · filed 2014-02-25 | $21.79M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2011-12-31 | $2.95M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $9.38M derived: sum of 2 quarters · filed 2014-02-25 | $12.99M derived: sum of 3 quarters · filed 2014-02-25 | $12.29M 10-K · filed 2014-02-25 | ||
| 2011-09-30 | $6.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $10.04M derived: sum of 2 quarters · filed 2012-11-09 | $9.35M 10-Q · filed 2012-11-09 | $17.31M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-06-30 | $3.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $2.92M 10-Q · filed 2012-08-07 | $10.88M derived: sum of 3 quarters · filed 2013-02-26 | $10.90M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-03-31 | -$698.00K 10-Q · filed 2012-05-08 | $7.27M derived: sum of 2 quarters · filed 2013-02-26 | $7.29M derived: sum of 3 quarters · filed 2013-02-26 | |||
| 2010-12-31 | $7.97M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $7.99M derived: sum of 2 quarters · filed 2013-02-26 | $9.77M 10-K · filed 2013-02-26 | |||
| 2010-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $1.80M 10-Q · filed 2011-11-08 | ||||
| 2010-06-30 | $1.78M 10-Q · filed 2011-08-03 | |||||
| 2009-12-31 | $5.67M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |